Pharmacy Owner Warned for Inadequate Oversight in Dispensing Prescriptions from Gender GP, UK Meds
Date of Decision: July 17, 2025
Registrant's Role: Pharmacist
Allegations:
- Dispensing medicines from unregulated online prescribing services (UK Meds and Gender GP).
- Failure to ensure clinical appropriateness and patient monitoring.
- Lack of due diligence and risk assessments in working with third-party prescribing services.
- Failure to obtain sufficient information from prescribers or patients' GPs.
- Inadequate communication and coordination with patients' primary care providers.
Outcome: Warning issued, to be published on the GPhC register for 12 months.
GPhC Standards Breached:
- Standard 1 – Pharmacy professionals must provide person-centred care
- Standard 2 – Pharmacy professionals must work in partnership with others
- Standard 3 – Pharmacy professionals must communicate effectively
- Standard 5 – Pharmacy professionals must use their professional judgement
- Standard 9 – Pharmacy professionals must demonstrate leadership
Case Summary
Allegations:
The case concerns a pharmacist who served as the co-owner, director, and Responsible Pharmacist of Kuramed Pharmacy. The focus of the allegations is the pharmacy’s collaboration with two online prescribing services—UK Meds Direct Ltd and Gender GP—between September 2021 and December 2022. These platforms were not regulated by any UK regulatory body, and in the case of Gender GP, prescribers operated from abroad.
Kuramed Pharmacy dispensed a range of prescription medications—including weight loss drugs and treatments for chronic conditions like asthma and diabetes—based on prescriptions issued through online questionnaires. These high-risk medications often require continuous clinical oversight and patient monitoring. However, the pharmacy failed to implement proper clinical checks and safeguards before dispensing, potentially exposing patients to harm. Many prescriptions lacked input from or communication with the patient’s GP, and some patients received repeated supplies without evidence of clinical appropriateness.
Continue Reading the Full Case
Create a free account or log in to access the complete case summary.
- Full allegations considered by the GPhC
- Panel findings and reasoning
- Outcome of the investigation
- Sanctions considered and imposed on the Pharmacist
- Key professional learning points
Original Case Document
View the Full Determination Document
The original determination transcript is available to registered users.
- Download the official GPhC determination
- Full hearing transcript
- Detailed findings of fact
- Sanction reasoning
- Details of the pharmacy professionals involved